Replimune Group Inc RP1 Program Update Call Transcript
Good day and thank you for standing by. Welcome to Replimune RP1 program update conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to Philip Astley-Sparke, Chief Executive Officer. Please go ahead.
Good morning and thank you for joining our investor conference call. We are pleased to have this opportunity to show everyone a comprehensive data update on the studies we are running with RP1 in multiple skin cancer setting. Before we begin, I need to highlight our forward-looking statements. On slide 3, I'm Philip Astley-Sparke, CEO of Replimune, and I have with me today from management, Dr. Robert Coffin, our President and Chief R&D Officer. We're also very pleased to have with us several leading physicians and sites over the considerable experience of using our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
